Literature DB >> 16807394

High Pseudomonas aeruginosa acquisition rate in CF.

B E van Ewijk, T F W Wolfs, A Fleer, J L L Kimpen, C K van der Ent.   

Abstract

Entities:  

Mesh：

Year:  2006        PMID： 16807394      PMCID： PMC2104671          DOI： 10.1136/thx.2006.062372

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  5 in total

1.  Monthly prevalence of group A, B and G Streptococcus, Haemophilus influenzae types E and F and Pseudomonas aeruginosa nasopharyngeal colonization in the first two years of life.

Authors:  H Faden
Journal:  Pediatr Infect Dis J       Date:  1998-03       Impact factor: 2.129

2.  Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.

Authors:  G Taccetti; S Campana; F Festini; M Mascherini; G Döring
Journal:  Eur Respir J       Date:  2005-09       Impact factor: 16.671

3.  Effects of upper respiratory tract infections in patients with cystic fibrosis.

Authors:  J Collinson; K G Nicholson; E Cancio; J Ashman; D C Ireland; V Hammersley; J Kent; C O'Callaghan
Journal:  Thorax       Date:  1996-11       Impact factor: 9.139

4.  Prospective surveillance for Pseudomonas aeruginosa cross-infection at a cystic fibrosis center.

Authors:  Andrew M Jones; Mary E Dodd; John R W Govan; Catherine J Doherty; Catherine M Smith; Barbara J Isalska; A Kevin Webb
Journal:  Am J Respir Crit Care Med       Date:  2004-11-12       Impact factor: 21.405

5.  A case-control study of acute respiratory tract infection in general practice patients in The Netherlands.

Authors:  Arianne B van Gageldonk-Lafeber; Marie-Louise A Heijnen; Aad I M Bartelds; Marcel F Peters; Simone M van der Plas; Berry Wilbrink
Journal:  Clin Infect Dis       Date:  2005-07-15       Impact factor: 9.079
  5 in total
  4 in total

Review 1.  The changing microbial epidemiology in cystic fibrosis.

Authors:  John J Lipuma
Journal:  Clin Microbiol Rev       Date:  2010-04       Impact factor: 26.132

2.  Broad-Spectrum Adaptive Antibiotic Resistance Associated with Pseudomonas aeruginosa Mucin-Dependent Surfing Motility.

Authors:  Evelyn Sun; Erin E Gill; Reza Falsafi; Amy Yeung; Sijie Liu; Robert E W Hancock
Journal:  Antimicrob Agents Chemother       Date:  2018-08-27       Impact factor: 5.191

3.  Increased Expression of Plasma-Induced ABCC1 mRNA in Cystic Fibrosis.

Authors:  Justin E Ideozu; Xi Zhang; Amy Pan; Zainub Ashrafi; Katherine J Woods; Martin J Hessner; Pippa Simpson; Hara Levy
Journal:  Int J Mol Sci       Date:  2017-08-11       Impact factor: 5.923

4.  First Wave of COVID-19 in French Patients with Cystic Fibrosis.

Authors:  Harriet Corvol; Sandra de Miranda; Lydie Lemonnier; Astrid Kemgang; Martine Reynaud Gaubert; Raphael Chiron; Marie-Laure Dalphin; Isabelle Durieu; Jean-Christophe Dubus; Véronique Houdouin; Anne Prevotat; Sophie Ramel; Marine Revillion; Laurence Weiss; Loic Guillot; Pierre-Yves Boelle; Pierre-Régis Burgel
Journal:  J Clin Med       Date:  2020-11-10       Impact factor: 4.241
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.